7 Stocks Poised to Profit From Coronavirus [Yahoo! Finance News]
Moderna, Inc. (MRNA)
Last moderna, inc. earnings: 2/26 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
marinabio.com/investor-relations
Company Research
Source: Yahoo! Finance News
In the wild throes of shaken markets, opportunity lurks. and investors alike have been badly shaken by the rapid spread of the coronavirus. have witnessed the Dow and the S&P 500's largest weekly declines since 2008 and a hasty response from the Federal Reserve. While the list of companies Moderna ticker: MRNA The best place to start is the pharmaceutical industry, where the battle against coronavirus presents a clear investment opportunity: The company that creates a vaccine for the virus will win big. Shares of Moderna shot up when the company announced it sent samples of its coronavirus vaccine to The National Institute of Allergy and Infectious Diseases, known as NIAID, and that clinical trials of the vaccine could start as early as April. The unprecedented speed of Moderna's vaccine development is a credit to the company's cutting-edge approach to developing medicines using messenger RNA, giving Moderna a quick lead in the vaccine race even though the company has never brought
Show less
Read more
Impact Snapshot
Event Time:
MRNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRNA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRNA alerts
High impacting Moderna, Inc. news events
Weekly update
A roundup of the hottest topics
MRNA
News
- Moderna Tops BioSpace's Best Places to Work Ranking for Fourth Consecutive YearAccesswire
- Moderna, Inc. (NASDAQ: MRNA) had its price target lowered by analysts at Barclays PLC from $125.00 to $111.00. They now have an "overweight" rating on the stock.MarketBeat
- Moderna (MRNA) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates [Yahoo! Finance]Yahoo! Finance
- Moderna, Inc. (NASDAQ: MRNA) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.MarketBeat
- Moderna Receives Health Canada Approval for RSV Vaccine for Adults Aged 60 Years and OlderAccesswire
MRNA
Earnings
- 11/7/24 - Beat
MRNA
Sec Filings
- 11/12/24 - Form 4
- 11/12/24 - Form 144
- 11/7/24 - Form 10-Q
- MRNA's page on the SEC website